1. 14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION. (April 2015) Authors: Komrokji, R.; Garcia-Manero, G.; Ades, L.; Laadem, A.; Vo, B.; Prebet, T.; Stamatoullas, A.; Boyd, T.; Delaunay, J.; Steensma, D.P.; Sekeres, M.A.; Beyne-Rauzy, O.; Zou, J.; Attie, K.M.; Sherman, M.L.; Fenaux, P.; List, A.F. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 217 DEFINING LIKELIHOOD OF FUTURE RESPONSE IN PATIENTS WITH DEL(5Q) MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH LENALIDOMIDE. Issue 1 (April 2015) Authors: Gerds, A.T.; List, A.F.; Giagounidis, A.; Hellström-Lindberg, E.; Li, J. Shiansong; Swern, A.S.; Sugrue, M.M.; Fenaux, P.; Sekeres, M.A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 310 RISK OF BONE MARROW FAILURE CONDITIONS IN PATIENTS UNDERGOING INVASIVE CARDIAC PROCEDURES. Issue 1 (April 2015) Authors: Ornstein, M.C.; Mukherjee, S.; Elson, P.; Pierce, C.; Zarzour, A.; Saunthararajah, Y.; Maggiotto, A.; Hobson, S.; Advani, A.S.; Gerds, A.T.; Carraway, H.; Kalaycio, M.; Maciejewski, J.P.; Ellis, S.; Blackstone, E.; Sekeres, M.A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 67 SUBCLASSIFICATION OF CHRONIC MYELOMONOCYTIC LEUKEMIA BY ANCESTRAL MUTATIONAL EVENTS. (April 2015) Authors: Patel, B.; Huang, D.; Thota, S.; Przychodzen, B.; Sakaguchi, H.; Kojima, S.; Ogawa, S.; Sekeres, M.A.; Makishima, H.; Maciejewski, J.P. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 79 RISK OF MYELODYSPLASTIC SYNDROMES IN WELL-DIFFERENTIATED THYROID CANCERS TREATED WITH RADIOACTIVE IODINE. (April 2015) Authors: Pleyer, C.; Sidana, S.; Erik, O.; Radivoyevitch, T.; Advani, A.S.; Gerds, A.T.; Carraway, H.; Kalaycio, M.; Maciejewski, J.P.; Sekeres, M.A.; Mukherjee, S. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 97 CHARACTERISTICS OF ROMIPLOSTIM-TREATED MDS PATIENTS WITH HEMATOLOGIC IMPROVEMENT IN PLATELETS (HI-P). Issue 1 (April 2015) Authors: Fenaux, P.; Muus, P.; Kantarjian, H.; Lyons, R.M.; Larson, R.A.; Sekeres, M.A.; Becker, P.S.; Orejudos, A.; Franklin, J. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Chromosomal Aberrations in Therapy-Related Myelodysplastic Syndromes – Relations to Primary Disease, Therapy and Prognostic Significance. (April 2017) Authors: Nomdedeu, M.; Tuechler, H.; Kuendgen, A.; Solé, F.; Schanz, J.; Hildebrandt, B.; Grau, J.; Pereira, A.; García-Manero, G.; Sekeres, M.A.; Komrokji, R.S.; Voso, M.T.; List, A.F.; Cazzola, M.; Sill, H.; Stauder, R.; Greenberg, P.; Germing, U.; Sanz, G.; Haase, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Enasidenib (AG-221), A Selective Oral Inhibitor of Mutant Isocitrate Dehydrogenase 2 (IDH2) Enzyme, In Patients with Myelodysplastic Syndromes (MDS). (April 2017) Authors: Stein, E.M.; Fathi, A.T.; DiNardo, C.D.; Pollyea, D.A.; Swords, R.T.; Roboz, G.J.; Collins, R.; Sekeres, M.A.; Stone, R.M.; Attar, E.C.; Tosolini, A.; Xu, Q.; Amatangelo, M.; Gupta, I.; Knight, R.D.; de Botton, S.; Tallman, M.S.; Kantarjian, H.M. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Epidemiology and risk factors for infections in myelodysplastic syndromes. Issue 6 (9th September 2013) Authors: Sullivan, L.R.; Sekeres, M.A.; Shrestha, N.K.; Maciejewski, J.P.; Tiu, R.V.; Butler, R.; Mossad, S.B. Journal: Transplant infectious disease Issue: Volume 15:Issue 6(2013) Page Start: 652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Rationale for Therapy Discontinuation in Patients with Lower-Risk Transfusion-Dependent Myelodysplastic Syndromes (LR-MDS). (April 2017) Authors: Gerds, A.T.; Gupta, S.; Sekeres, M.A.; Nazha, A.; Carraway, H.E.; Hawthorne, S.; King-Concialdi, K.; McGuire, M. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗